ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 187 filers reported holding ANI PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,593 | +5.7% | 165,229 | -2.0% | 0.02% | +6.7% |
| Q2 2023 | $9,079 | +119.8% | 168,655 | +62.1% | 0.02% | +114.3% |
| Q1 2023 | $4,131 | -31.2% | 104,012 | +96207.4% | 0.01% | – |
| Q3 2018 | $6,000 | -14.3% | 108 | 0.0% | 0.00% | – |
| Q2 2018 | $7,000 | +16.7% | 108 | 0.0% | 0.00% | – |
| Q1 2018 | $6,000 | -14.3% | 108 | 0.0% | 0.00% | – |
| Q4 2017 | $7,000 | -66.7% | 108 | -73.5% | 0.00% | – |
| Q3 2017 | $21,000 | +16.7% | 408 | +8.2% | 0.00% | – |
| Q2 2017 | $18,000 | +200.0% | 377 | +211.6% | 0.00% | – |
| Q1 2017 | $6,000 | 0.0% | 121 | +17.5% | 0.00% | – |
| Q4 2016 | $6,000 | -14.3% | 103 | 0.0% | 0.00% | – |
| Q3 2016 | $7,000 | +16.7% | 103 | 0.0% | 0.00% | – |
| Q2 2016 | $6,000 | +50.0% | 103 | -18.9% | 0.00% | – |
| Q1 2016 | $4,000 | -63.6% | 127 | -48.4% | 0.00% | – |
| Q4 2015 | $11,000 | – | 246 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
| AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
| Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
| Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
| Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
| Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
| EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
| Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |